Hingham Savings Reports 2023 Results
HINGHAM, Mass., Jan. 19, 2024 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the […]
5E Advanced Materials Closes First Tranche of Equity Financing Following Special Meeting
HESPERIA, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), […]
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 26, 2024
GREENWICH, Conn., Jan. 19, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) […]
Lee Enterprises plans quarterly call and webcast February 1, 2024
DAVENPORT, Iowa, Jan. 19, 2024 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE), a major subscription and advertising platform and […]
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.28 PER COMMON SHARE
New York, Jan. 19, 2024 (GLOBE NEWSWIRE) — Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors […]
Fitell Corporation Announces Private Placement of US$3.6 Million of Senior Unsecured Convertible Notes
TAREN POINT, Australia, Jan. 19, 2024 (GLOBE NEWSWIRE) — Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer […]
Five Star Bancorp Declares Fourth Quarter 2023 Cash Dividend
RANCHO CORDOVA, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”) announced […]
Bank of the James Financial Group, Inc. Announces Quarterly Dividend; Increases Quarterly Dividend by 25%
LYNCHBURG, Va., Jan. 19, 2024 (GLOBE NEWSWIRE) — On January 16, 2024, the Board of Directors of Bank of the […]
Sun Country Airlines Will Hold Its Fourth Quarter and Full Year 2023 Earnings Conference Call February 1
MINNEAPOLIS, Jan. 19, 2024 (GLOBE NEWSWIRE) — Sun Country Airlines (NASDAQ: SNCY) will hold its fourth quarter and full year […]
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today […]
